现代向治疗和免疫治疗在皮肤恶性病患者的皮肤副作用
Kerasia-Maria Plachouri1, Vaia Florou2, Vasileios Georgiou3
1Dermatology Department, University General Hospital of Patras, University of Patras, 265 04 Rio, Greece.
Cancers
|June 28, 2023
概括
新的皮肤癌治疗方法,如免疫疗法和向疗法是有效的,但可能会导致皮肤副作用. 了解这些毒性是管理患者护理和治疗成功的关键.
科学领域:
- 皮肤瘤学 皮肤瘤学
- 免疫治疗是一种免疫疗法.
- 有针对性的治疗.
背景情况:
- 免疫疗法和向疗法彻底改变了皮肤瘤学,与传统化疗相比,在治疗黑色素瘤和晚期基底细胞/状细胞癌等皮肤癌方面具有更高的疗效.
- 虽然这些先进的治疗方法非常有效,但可能会导致显著的皮肤不良事件,影响患者的生活质量和治疗坚持.
研究的目的:
- 提供与免疫检查点抑制剂和用于皮肤瘤学的向治疗相关的皮肤副作用的全面概述.
- 强调识别和管理与治疗相关的皮肤毒性的重要性,以优化患者的治疗结果.
主要方法:
- 关于当前免疫疗法和向药物的皮肤学副作用的文献综述和数据综合.
- 分析报告的不良事件概况及其对治疗皮肤恶性瘤的临床影响.
主要成果:
- 这些先进疗法的大部分皮肤毒性是轻微的,但可能需要调整治疗.
- 皮肤不良事件的特定模式与不同类型的免疫疗法和向药物有关.
结论:
- 对于皮肤科医生和瘤科医生来说,了解免疫检查点抑制剂和向治疗的独特皮肤毒性概况至关重要.
- 皮肤副作用的积极管理对于维持治疗连续性和改善皮肤瘤治疗患者的整体生活质量至关重要.
相关概念视频
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Skin Diseases and Disorders
3.9K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
3.9K
Cytotoxic T Cells-mediated Immune Response
998
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
998
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K


